Related by context. Frequent words. (Click for all words.) 74 superficial bladder cancer 74 mRCC 73 forodesine 73 gastrointestinal stromal tumors GIST 73 recurrent glioblastoma 73 PREZISTA r 72 metastatic renal cell carcinoma 72 relapsing multiple sclerosis 72 refractory chronic lymphocytic 72 heavily pretreated 72 HER2 positive metastatic breast 71 relapsed refractory multiple myeloma 71 malignant pleural mesothelioma 71 metastatic castration resistant 71 phase IIb clinical 71 glioblastoma multiforme GBM 71 relapsed multiple myeloma 71 Idiopathic Pulmonary Fibrosis 71 Natalizumab 71 leukemia CLL 70 allogeneic stem cell 70 neoadjuvant therapy 70 acute promyelocytic leukemia APL 70 colorectal carcinoma 70 pheochromocytoma 70 metastatic hormone refractory 70 nab paclitaxel 70 Cytoxan 70 EGFR expressing mCRC 70 sunitinib malate 70 pertuzumab 70 tumor lysis syndrome 70 corticosteroid therapy 70 Amrubicin 69 leukemia ALL 69 mycophenolate mofetil 69 resectable 69 Fibrillex TM 69 Golimumab 69 chemoradiotherapy 69 Alemtuzumab 69 HNSCC 69 nephrotoxicity 69 non squamous NSCLC 69 bendamustine 69 docetaxel chemotherapy 69 multiple myeloma MM 69 Dasatinib 68 mg kg dose 68 GSK# [001] 68 heparin induced thrombocytopenia 68 gastrointestinal stromal tumors 68 bleomycin 68 vandetanib 68 neoadjuvant chemotherapy 68 Epratuzumab 68 Ischemic 68 Traficet EN 68 RRMS patients 68 HBeAg positive 68 receiving VELCADE 68 plus dexamethasone 68 hepatitis C HCV 68 Pivotal Phase III 68 hematologic toxicity 68 AA amyloidosis 68 hepatocellular carcinoma HCC 68 Irinotecan 68 ximelagatran 68 Trastuzumab 68 pericardial effusion 68 lymphoma CTCL 68 advanced carcinoid 68 ThermoDox R 68 Chronic Hepatitis C 68 Proxinium TM 67 liposomal formulation 67 primary hypercholesterolemia 67 IV metastatic melanoma 67 Daclizumab 67 cabazitaxel 67 androgen deprivation 67 DOXIL 67 secondary hyperparathyroidism 67 liver transplant recipients 67 relapsing remitting multiple sclerosis 67 carcinoid tumors 67 immune modulator 67 relapsing MS 67 Tavocept 67 FOLFOX4 67 lupus nephritis 67 tigecycline 67 tanespimycin 67 murine model 67 Metastatic Melanoma 67 acute promyelocytic leukemia 67 fluvastatin 67 acute myelogenous leukemia AML 67 elotuzumab 67 olmesartan